Tyrosine Kinase Inhibitor PTK/ZK Enhances the Antitumor Effects of Interferon-α/5-Fluorouracil Therapy for Hepatocellular Carcinoma Cells

被引：0
|
作者：
Masahiro Murakami
Shogo Kobayashi
Shigeru Marubashi
Yoshito Tomimaru
Takehiro Noda
Hiroshi Wada
Hidetoshi Eguchi
Yutaka Takeda
Masahiro Tanemura
Koji Umeshita
Yuichiro Doki
Masaki Mori
Hiroaki Nagano
机构：
[1] Osaka University,Department of Surgery, Graduate School of Medicine
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
Vascular Endothelial Growth Factor; Sorafenib; HuH7 Cell; Vascular Endothelial Growth Factor Signaling; Portal Vein Tumor Thrombus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：589 / 596
页数：7
相关论文
共 50 条
  • [21] MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
    Y Tomimaru
    H Eguchi
    H Nagano
    H Wada
    A Tomokuni
    S Kobayashi
    S Marubashi
    Y Takeda
    M Tanemura
    K Umeshita
    Y Doki
    M Mori
    British Journal of Cancer, 2010, 103 : 1617 - 1626
  • [22] A pilot study of interferon alpha and 5-fluorouracil in hepatocellular carcinoma
    Mughal, TI
    Koriech, OM
    ACTA ONCOLOGICA, 1996, 35 (02) : 248 - 248
  • [23] Pilot study of interferon alpha and 5-fluorouracil in hepatocellular carcinoma
    Acta Oncol, 2 (248):
  • [24] MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells
    Tomimaru, Y.
    Eguchi, H.
    Nagano, H.
    Wada, H.
    Tomokuni, A.
    Kobayashi, S.
    Marubashi, S.
    Takeda, Y.
    Tanemura, M.
    Umeshita, K.
    Doki, Y.
    Mori, M.
    BRITISH JOURNAL OF CANCER, 2010, 103 (10) : 1617 - 1626
  • [25] Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
    Deng, Lifen
    Ren, Zhenggang
    Jia, Qingan
    Wu, Weizhong
    Shen, Hujia
    Wang, Yanhong
    BMC CANCER, 2013, 13
  • [26] Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
    Lifen Deng
    Zhenggang Ren
    Qingan Jia
    Weizhong Wu
    Hujia Shen
    Yanhong Wang
    BMC Cancer, 13
  • [27] Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-α combination chemotherapy
    Moriyama, M
    Hoshida, Y
    Kato, N
    Otsuka, M
    Yoshida, H
    Kawabe, T
    Omata, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (05) : 1279 - 1287
  • [28] Similar effects of recombinant interferon-α-2b and natural interferon-α when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma
    Uka, Kiminori
    Aikata, Hiroshi
    Takaki, Shintaro
    Miki, Daiki
    Jeong, Soo Cheol
    Hiramatsu, Akira
    Kodama, Hideaki
    Shirakawa, Hiroo
    Kawakami, Yoshiiku
    Takahashi, Shoichi
    Toyota, Naoyuki
    Ito, Katsuhide
    Chayama, Kazuaki
    LIVER INTERNATIONAL, 2007, 27 (09) : 1209 - 1216
  • [29] Biomodulation of 5-fluorouracil by interferon-α in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase
    Tatsuo Morita
    Akihiko Tokue
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 91 - 96
  • [30] Biomodulation of 5-fluorouracil by interferon-α in human renal carcinoma cells:: relationship to the expression of thymidine phosphorylase
    Morita, T
    Tokue, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (02) : 91 - 96
12345